TCM
AMED

Tygh Capital Management’s Amedisys AMED Stock Holding History

Tygh Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-29,177
Closed -$5.36M – 80
2020
Q1 		$5.36M Buy
+29,177
New +$5.19M 1.2% 41
2018
Q3 		– Sell
-35,750
Closed -$3.06M – 85
2018
Q2 		$3.06M Sell
35,750
-113,422
-76% -$8.33M 0.52% 79
2018
Q1 		$9M Buy
149,172
+34,207
+30% +$1.95M 1.71% 11
2017
Q4 		$6.06M Buy
114,965
+61,073
+113% +$3.22M 1.14% 31
2017
Q3 		$3.02M Buy
+53,892
New +$2.85M 0.6% 75
2017
Q2 		– Sell
-68,807
Closed -$3.52M – 88
2017
Q1 		$3.52M Sell
68,807
-57,435
-45% -$2.74M 0.82% 62
2016
Q4 		$5.38M Buy
+126,242
New +$5.37M 1.35% 28

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tygh Capital Management's AMED Position: Q2 2020 in Review

Tygh Capital Management sold out of Amedisys (AMED) in Q2 2020, closing a stake of 29,177 shares — an estimated $5.36M sold.

Tygh Capital Management first reported a position in AMED in Q4 2016 and held it in 7 quarters. The position peaked at $9M in Q1 2018. 355 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

  • Tygh Capital Management reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
  • Tygh Capital Management sold 29,177 Amedisys shares in Q2 2020, an estimated $5.36M.
  • Tygh Capital Management first reported a position in Amedisys in Q4 2016 and held it in 7 quarters.
  • Tygh Capital Management's Amedisys position peaked at $9M in Q1 2018.
  • 355 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Tygh Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.